Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Pharm Sci. 2017 Dec 14;107(4):1194–1203. doi: 10.1016/j.xphs.2017.12.004

Table 4.

Model-derived estimates of β-adjustment factor for enhancement of basolateral membrane clearance by MK-571 and glyceollin, and CDFDA hydrolysis clearance by genistein.

Agent Apical Dosing Parameter Estimates (% RSE) Basolateral Dosing Parameter Estimates (% RSE)

Clhydrolysis Clcdf,bl Clhydrolysis Clcdf,bl

MK-571 ---- 1.7 × 10−2 (<0.1) ---- 2.4 × 10−2 (0.4)
Glyceollin ---- 2.2 × 10−2 (<0.1) ---- 1.8 × 10−2 (2.9)
Genistein 6.9 × 10−3 (<0.1) ---- 2.8 × 10−2 (0.6) ----